2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-

CAS : 1665-48-1

Ref. AN-AG001WRZ

Informations sur le produit

• Nom: 2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-
• Synonymes: [u'AHR 438', u'metaxalone', u'Skelaxin', u'METAXALONE', u'1665-48-1', u'Skelaxin', u'Methaxalonum', u'Metaxalon', u'Zorane', u'Methoxolone', u'5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one', u'Metazalone', u'Metazolone', u'Metaxolone', u'AHR-438', u'Metaxalonum [Latin]', u'Metassalone [DCIT]', u'Metaxalonum [INN-Latin]', u'Metassalone', u'Metaxalona [INN-Spanish]', u'Metaxalonum', u'Metaxalona', u'AHR 438', u'5-(3,5-Xyloloxymethyl)oxazolidin-2-one', u'Metaxalona [Spanish]', u'CL 39,148', u'2-Oxazolidinone, 5-((3,5-xylyloxy)methyl)-', u'NSC 170959', u'5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one', u'Metaxalone [USAN:INN:BAN]', u'5-((3,5-Dimethylphenoxy)methyl)-2-oxazolidinone', u'HSDB 3236', u'5-((3,5-Xylyloxy)methyl)-2-oxazolidinone', u'5-[(3,5-Xylyloxy)methyl]-2-oxazolidinone', u'EINECS 216-777-6', u'5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one', u'BRN 0884592', u'MLS003106749', u'CHEBI:6797', u'IMWZZHHPURKASS-UHFFFAOYSA-N', u'5-[(3,5-Dimethylphenoxy)methyl]-2-oxazolidinone', u'MFCD00867700', u'NSC170959', u'NCGC00095116-01', u'DSSTox_CID_3269', u'2-Oxazolidinone, 5-[(3,5-xylyloxy)methyl]-', u'5-(3,5-dimethylphenoxymethyl)-2-oxazolidinone', u'DSSTox_RID_76949', u'DSSTox_GSID_23269', u'5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one', u'CAS-1665-48-1', u'SR-05000001978', u'5-((3,5-Dimethylphenoxy)methyl)-1,3-oxazolidin-2-one', u'.meta.Xalone', u'.meta.Zalone', u'.meta.Zolone', u'.meta.Xalon', u'Skelaxin (TN)', u'Spectrum_001741', u'SpecPlus_000656', u'AC1Q6MIL', u'Metaxalone (USAN/INN)', u'Spectrum2_000548', u'Spectrum3_001666', u'Spectrum4_000612', u'Spectrum5_001685', u'AC1L25XO', u'Oprea1_438855', u'SCHEMBL34908', u'BSPBio_003451', u'KBioGR_001164', u'KBioSS_002221', u'DivK1c_006752', u'SPECTRUM1504229', u'SPBio_000595', u'GTPL7609', u'CHEMBL1079604', u'DTXSID3023269', u'Metaxalone, >=98% (HPLC)', u'CTK8F0377', u'KBio1_001696', u'KBio2_002221', u'KBio2_004789', u'KBio2_007357', u'KBio3_002671', u'HMS1922H07', u'HMS2093C22', u'Pharmakon1600-01504229', u'BCP28377', u'HY-B0678', u'KS-00000ZH8', u'Tox21_111428', u'WLN: T5MVOTJ D1OR C1 E1', u'2-Oxazolidinone,5-xylyloxy)methyl]-', u'CCG-39592', u'NSC758703', u'STL450994', u'STL451511', u'AKOS009035315', u'Tox21_111428_1', u'CS-2910', u'DB00660', u'FS-3218', u'MCULE-3101469866', u'NSC-170959', u'NSC-758703', u'TRA0047745', u'5-(3,5-xylyloxymethyl)-2-oxazolidone', u'NCGC00095116-02', u'NCGC00095116-03', u'NCGC00095116-05', u'AK-61006', u'BC220747', u'BR-61006', u'SMR001821638', u'SBI-0052859.P002', u'2-Oxazolidinone,5-dimethylphenoxy)methyl]-', u'AB0063964', u'LS-100704', u'TR-035874', u'4CH-009638', u'AM20060525', u'FT-0603568', u'M2578', u'ST24029254', u'5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone', u'C07934', u'D00773', u'S-2010', u'5-((3,5-dimethylphenoxy)methyl)-2-oxazolidinon', u'AB00053284_04', u'665M481', u'A810747', u'I06-0370', u'J-010295', u'SR-05000001978-1', u'SR-05000001978-3', u'BRD-A94709349-001-02-6', u'BRD-A94709349-001-03-4', u'5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one #', u'5-{[(3,5-dimethylphenyl)oxy]methyl}-1,3-oxazolidin-2-one', u'5-[(3,5-dimethylphenoxy)methyl]-4,5-dihydro-1,3-oxazol-2-ol', u'Metaxalone, United States Pharmacopeia (USP) Reference Standard'], 2-Oxazolidinone, 5-[(3,5-xylyloxy)methyl]-, 5-[(3,5-Dimethylphenoxy)methyl]-2-oxazolidinone, 5-[(3,5-Xylyloxy)methyl]-2-oxazolidinone, Ahr 438, Flexura, Metaxalon, Metaxalona, Metaxalone, Metazalone, Metazolone, Nsc 170959, Rac-5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one, Skelaxin, Zorane
• CAS: 1665-48-1
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 221.2524
• Formule: C₁₂H₁₅NO₃
• Degré de pureté: 98%
• Couleur/Forme: Solid
• InChI: InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)
• Code InChI: IMWZZHHPURKASS-UHFFFAOYSA-N